Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
982.9 INR | -0.71% | -0.21% | +21.14% |
May. 08 | AstraZeneca, Merck Sue to Protect Lynparza Cancer Drug Patents | MT |
May. 08 | AstraZeneca, Merck Sue to Protect Lynparza Cancer Drug Patents | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+21.14% | 2.12B | |
+30.96% | 588B | |
-3.42% | 364B | |
+18.02% | 326B | |
+4.27% | 285B | |
+14.79% | 239B | |
+10.12% | 210B | |
-6.99% | 200B | |
+8.12% | 167B | |
-1.42% | 161B |
- Stock Market
- Equities
- NATCOPHARM Stock
- News NATCO Pharma Limited
- Natco Pharma Limited Appoints Nitin Deshmukh as Additional Director